The Centers for Disease Control and Prevention, which claims that it poses a major danger to world health, revealed that 5,754 instances we...

This is the fifth detailed report on antimicrobial resistance (AMR) trends and patterns from the country published by the ICMR. This year's...

The Union Health Ministry has suggested amendments to the Drugs Rules, 1945, to bring 16 such medicines under Schedule K for providing exem...

The DTAB has approved a list of OTC drugs which includes medicines like antifungal infections, analgesics (pain killers), cough syrups, dec...

Drugmaker Cipla said it is scaling up offerings and expanding access to medicines, inhaler devices, diagnostics, as it aspires to become th...

India’s drug regulator is examining the use of alternative drugs for the treatment of mucormycosis, the fungal infection which has become t...

Two injections are being provided to the states by the Union government in the treatment of black fungus. No one can procure these medicine...

MSN Labs had earlier launched a Covid treatment portfolio of Favilow (Favipiravir) in the strengths of 200mg, 400mg and 800mg, Oselow (Osel...

In addition to the shortage, the treatment for this invasive fungal infection is a costly affair requiring Rs 15,000-Rs 20,000 per day for ...

US-based private equity fund Advent International has signed a definitive agreement to acquire a majority stake in Bharat Serums and Vaccin...

DTAB, country’s highest drug advisory body, will discuss a mechanism to this effect at its meeting on Thursday because the problem is exten...

The 92-year-old politician was admitted to Max Hospital, Saket on September 20 last year after suffering a brain stroke.

As a result of the court's order, the ban on sale of P&G's Vicks Action 500 extra, Reckitt's D'Cold and Piramal's Saridon have been lifted ...

Team of experts at AIIMS are closely monitoring Jammu and Kashmir Chief Minister Mufti Mohammad Sayeed's condition in ICU.

Drug firm Lyka Labs has sold its formulation manufacturing unit at Tarapur for Rs 38.61 crore.

Separate reports have said the world's 2nd largest drugmaker has now shifted the research programme to Aurigine, a wholly-owned drug discov...